Literature DB >> 7625646

Vaccine strategies: targeting helper T cell responses.

B Golding1, D E Scott.   

Abstract

Vaccine strategies need to take into account the balance of T helper subsets they induce. TH1 cells, which secrete IFN gamma and IL-2, are associated with CMI, rather than humoral responses, and afford protection against intracellular infections including parasites. In contrast, TH2 cells secrete IL-4, IL-5, and IL-10; elicit high-titer antibody responses and poor CMI; and are associated with susceptibility to infection with intracellular pathogens. Depending on the type of TH cell bias required, it is possible to manipulate the immune response to a protein or peptide by employing (1) different adjuvants, (2) conjugating the protein to various carriers, (3) immunizing in the presence of cytokines, (4) using alternative routes of administration, or (5) using different forms or doses of antigen. To apply these approaches to a particular vaccine, it is necessary to identify which component of the infectious agent (e.g., envelope protein or peptide) or allergen to target. Once the type of TH cell response that is protective is identified, it may be possible to combine a protein with an adjuvant or link it to a carrier that will promote responses towards the most advantageous TH subset.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7625646     DOI: 10.1111/j.1749-6632.1995.tb44445.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

Review 1.  DNA-antiviral vaccines: new developments and approaches--a review.

Authors:  M Giese
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

2.  Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.

Authors:  Juliana Cassataro; Silvia M Estein; Karina A Pasquevich; Carlos A Velikovsky; Silvia de la Barrera; Raúl Bowden; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Recombinant Ochrobactrum anthropi expressing Brucella abortus Cu,Zn superoxide dismutase protects mice against B. abortus infection only after switching of immune responses to Th1 type.

Authors:  Yongqun He; Ramesh Vemulapalli; Gerhardt G Schurig
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Cloning, expression, and characterization of Schistosoma japonicum tegument protein phosphodiesterase-5.

Authors:  Min Zhang; Yanhui Han; Zhu Zhu; Dong Li; Yang Hong; Xiujuan Wu; Zhiqiang Fu; Jiaojiao Lin
Journal:  Parasitol Res       Date:  2011-07-22       Impact factor: 2.289

5.  Immunization with recombinant Sao protein confers protection against Streptococcus suis infection.

Authors:  Yuanyi Li; Marcelo Gottschalk; Miriam Esgleas; Sonia Lacouture; J Daniel Dubreuil; Philip Willson; Josee Harel
Journal:  Clin Vaccine Immunol       Date:  2007-06-13

6.  Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults.

Authors:  Stéphane Pillet; Julie Couillard; Sonia Trépanier; Jean-François Poulin; Bader Yassine-Diab; Bruno Guy; Brian J Ward; Nathalie Landry
Journal:  PLoS One       Date:  2019-06-05       Impact factor: 3.240

7.  Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.

Authors:  Ane Ogbe; Matthew Pace; Mustapha Bittaye; Timothy Tipoe; Sandra Adele; Jasmini Alagaratnam; Parvinder K Aley; M Azim Ansari; Anna Bara; Samantha Broadhead; Anthony Brown; Helen Brown; Federica Cappuccini; Paola Cinardo; Wanwisa Dejnirattisai; Katie J Ewer; Henry Fok; Pedro M Folegatti; Jamie Fowler; Leila Godfrey; Anna L Goodman; Bethany Jackson; Daniel Jenkin; Mathew Jones; Stephanie Longet; Rebecca A Makinson; Natalie G Marchevsky; Moncy Mathew; Andrea Mazzella; Yama F Mujadidi; Lucia Parolini; Claire Petersen; Emma Plested; Katrina M Pollock; Thurkka Rajeswaran; Maheshi N Ramasamy; Sarah Rhead; Hannah Robinson; Nicola Robinson; Helen Sanders; Sonia Serrano; Tom Tipton; Anele Waters; Panagiota Zacharopoulou; Eleanor Barnes; Susanna Dunachie; Philip Goulder; Paul Klenerman; Gavin R Screaton; Alan Winston; Adrian Vs Hill; Sarah C Gilbert; Miles Carroll; Andrew J Pollard; Sarah Fidler; Julie Fox; Teresa Lambe; John Frater
Journal:  JCI Insight       Date:  2022-04-08

8.  A Schistosoma japonicum chimeric protein with a novel adjuvant induced a polarized Th1 immune response and protection against liver egg burdens.

Authors:  Xindong Xu; Dongmei Zhang; Wei Sun; Qingfeng Zhang; Jingjing Zhang; Xiangyang Xue; Luhui Shen; Weiqing Pan
Journal:  BMC Infect Dis       Date:  2009-05-06       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.